approval to sell its new Promus Element drug-eluting stent in Europe, replacing the Promus stent it co-markets with Abbott Laboratories. The company said it will immediately begin selling the stent in the European Union. A supply agreement with Abbott...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Boston Sci Promus Element stent approved in Europe
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account